<DOC>
	<DOCNO>NCT00571194</DOCNO>
	<brief_summary>Many child end stage renal disease develop hyperlipidemia . HMG-CoA ( 3-hydroxy-3-methylglutaryl-coenzyme A ) reductase inhibitor , pravastatin , typical treatment hyperlipidemia . However , know pravastatin metabolized patient dialysis . This study design provide preliminary pharmacokinetic data pravastatin pediatric patient peritoneal dialysis .</brief_summary>
	<brief_title>Single Dose Pravastatin Pharmacokinetics Pediatric Peritoneal Dialysis Patients</brief_title>
	<detailed_description>This single-dose pilot study evaluate pharmacokinetic profile pravastatin 7 pediatric adolescent subject range 12 month 16 year age dialysis . The study group comprise healthy child receive continuous cycle peritoneal dialysis ( CCPD ) . Pravastatin dose 10 mg subject . Blood , urine , dialysate sample obtain 24-hour period post-dose measurement pravastatin concentration . Safety evaluation include adverse event ( AEs ) , physical examination , vital sign , clinical laboratory evaluation .</detailed_description>
	<mesh_term>Kidney Failure , Chronic</mesh_term>
	<mesh_term>Pravastatin</mesh_term>
	<criteria>1 . Patients 12 month 18 year age . 2 . Patients end stage renal disease receive continuous cycling peritoneal dialysis . 3. sign inform consent 4 . Physical exam demonstrate abnormality would make study medically hazardous subject . 1 . Any clinically significant unstable medical condition chronic disease associate ESRD . 2 . Any clinically significant illness within 10 day receive singlesdoe study medication 3 . History rhabdomyolysis 4 . Clinically significant liver disease history malabsorption previous gastrointestinal surgery could effect drug absorption metabolism . 5 . Clinical laboratory abnormality : Aspartate aminotransferase ( AST ) , Alanine Aminotransferase ( ALT ) , Creatine phosphokinase ( CPK ) &gt; 2.5 time upper limit normal ; hemoglobin &lt; 8.5 g.dL . 6 . Known hypersensitivity pravastatin 7 . Unwilling blood sample draw 8 . Has take HMGCoA reductase inhibitor last week</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Years</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>pravastatin , peritoneal dialysis , pediatric patient</keyword>
</DOC>